camrelizumab
Showing 1 - 5 of 5
Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)
Not yet recruiting
- Liver Diseases
- +4 more
- bTAE-HAIC
- +2 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 24, 2023
Breast Cancer, Triple Negative Breast Cancer, Camrelizumab Trial in Zhengzhou ((Carrelizumab + TCb) regimen, TCb regimen)
Recruiting
- Breast Cancer
- +2 more
- （Carrelizumab + TCb） regimen
- TCb regimen
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Jul 24, 2022
Uterine Cervical Tumors, Oncolytic Virotherapy, Camrelizumab Trial in China (Recombinant human adenovirus type 5+Camrelizumab)
Not yet recruiting
- Uterine Cervical Neoplasms
- +2 more
- Recombinant human adenovirus type 5＋Camrelizumab
-
Hangzhou, Zhejiang, China
- +3 more
Feb 8, 2022
Nasal Cavity Cancer, Paranasal Sinus Cancer, Camrelizumab Trial in Guangzhou (camrelizumab)
Recruiting
- Nasal Cavity Cancer
- +5 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 9, 2021